Phase II feasibility study of adjuvant S-1 plus CPT-11 for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0801).

被引:0
|
作者
Kimura, Yutaka
Fujitani, Kazumasa
Ueda, Shugo
Taniguchi, Hirokazu
Imamura, Hiroshi
Gofuku, Junji
Tamura, Shigeyuki
Kurokawa, Yukinori
Takiuchi, Hiroya
Furukawa, Hiroshi
机构
[1] NTT West Osaka Hosp, Dept Surg, Osaka, Japan
[2] Osaka Natl Hosp, Osaka, Japan
[3] Kitano Hosp, Dept Surg, Osaka, Japan
[4] NTT West Osaka Hosp, Osaka, Japan
[5] Sakai Municipal Hosp, Sakai, Osaka, Japan
[6] Kaizuka Municipal Hosp, Dept Surg, Kaizuka, Japan
[7] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
[8] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan
[9] Osaka Med Coll, Osaka, Japan
[10] Sakai Municipal Hosp, Dept Surg, Sakai, Osaka, Japan
关键词
D O I
10.1200/jco.2012.30.4_suppl.142
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
142
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002)
    Matsuyama, Jin
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Imamura, Hiroshi
    Fujita, Junya
    Iljima, Shohei
    Ueda, Shugo
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604).
    Matsuyama, Jin
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604)
    Fujitani, K.
    Tamura, S.
    Kimura, Y.
    Tsuji, T.
    Matsuyama, J.
    Iijima, S.
    Imamura, H.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Matsuyama, Jin
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    ONCOLOGY, 2011, 80 (5-6) : 296 - 300
  • [5] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
    Shitara, Kohei
    Chin, Keisho
    Yoshikawa, Takaki
    Katai, Hitoshi
    Terashima, Masanori
    Ito, Seiji
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Tsujinaka, Toshimasa
    GASTRIC CANCER, 2017, 20 (01) : 175 - 181
  • [6] Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
    Kohei Shitara
    Keisho Chin
    Takaki Yoshikawa
    Hitoshi Katai
    Masanori Terashima
    Seiji Ito
    Motohiro Hirao
    Kazuhiro Yoshida
    Eiji Oki
    Mitsuru Sasako
    Yasunori Emi
    Toshimasa Tsujinaka
    Gastric Cancer, 2017, 20 : 175 - 181
  • [7] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Kazumasa Fujitani
    Shigeyuki Tamura
    Yutaka Kimura
    Jin Matsuyama
    Hiroshi Imamura
    Kazuyoshi Yamamoto
    Junya Fujita
    Shohei Iijima
    Shugo Ueda
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    Gastric Cancer, 2020, 23 : 520 - 530
  • [8] Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Matsuyama, Jin
    Imamura, Hiroshi
    Yamamoto, Kazuyoshi
    Fujita, Junya
    Iijima, Shohei
    Ueda, Shugo
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    GASTRIC CANCER, 2020, 23 (03) : 520 - 530
  • [9] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002)
    Ryohei, Kawabata
    Kazumasa, Fujitani
    Shigeyuki, Tamura
    Yutaka, Kimura
    Hiroshi, Imamura
    Junya, Fujita
    Jin, Matsuyama
    Shohei, Iijima
    Shugo, Ueda
    Yukinori, Kurokawa
    Daisuke, Sakai
    Toshio, Shimokawa
    Toshimasa, Tsujinaka
    Hiroshi, Furukawa
    Taroh, Satoh
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy
    Kazumasa Fujitani
    Shigeyuki Tamura
    Yutaka Kimura
    Takeshi Tsuji
    Jin Matsuyama
    Shohei Iijima
    Hiroshi Imamura
    Kentaro Inoue
    Kenji Kobayashi
    Yukinori Kurokawa
    Toshio Shimokawa
    Toshimasa Tsujinaka
    Hiroshi Furukawa
    Gastric Cancer, 2014, 17 : 348 - 353